Dr. Jessica Oloriz

Pharmacist



  
  19210 Jamboree Rd, Irvine
California, 92612-2502

 714-456-8000   
Dr. Jessica Oloriz is a pharmacist in Irvine, California. Patients can reach her at 19210 Jamboree Rd, Irvine or contact her on 714-456-8000. Active license number of Dr. Jessica Oloriz is 90921 for Pharmacist in California.
Dr. Jessica Oloriz is


Complete Profile:
Dr. Jessica Oloriz speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Dr. Jessica Oloriz
Specialization: Pharmacist
Gender:Female
Location:19210 Jamboree Rd, Irvine,
California, 92612-2502
Phone:714-456-8000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Jessica Oloriz are as mentioned below.
NPI Number: 1386568848
NPI Enumeration Date: 07 Aug, 2026
NPI Last Update On: 07 Aug, 2026

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jessica Oloriz are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 90921CaliforniaPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 385 S Manchester Ave Unit 3077,
Orange, California
Zip: 92868-3257
Phone Number: 916-365-7125
Patients can reach Dr. Jessica Oloriz at 19210 Jamboree Rd, Irvine, California or can call on phone at 714-456-8000.

Comments/ Reviews:
Read all the reviews posted for Dr. Jessica Oloriz below. You may also share your own experience with Dr. Jessica Oloriz. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.